An apolipoprotein E-mimetic stimulates axonal regeneration and remyelination after peripheral nerve injury.
Elevated apolipoprotein E (apoE) synthesis within crushed sciatic nerves advocates that apoE could benefit axonal repair and reconstruction of axonal and myelin membranes. We created an apoE-mimetic peptide, COG112 (acetyl-RQIKIWFQNRRMKWKKCLRVRLASHLRKLRKRLL-amide), and found that postinjury treatment with COG112 significantly improved recovery of motor and sensory function following sciatic nerve crush in C57BL/6 mice. Morphometric analysis of injured sciatic nerves revealed that COG112 promoted axonal regrowth after 2 weeks of treatment. More strikingly, the thickness of myelin sheaths was increased by COG112 treatment. Consistent with these histological findings, COG112 potently elevated growth associated protein 43 (GAP-43) and peripheral myelin protein zero (P0), which are markers of axon regeneration and remyelination, respectively. Electron microscopic examination further suggested that the apoE-mimetic COG112 may increase clearance of myelin debris. Schwann cell uptake of cholesterol-containing low-density lipoprotein particles was selectively enhanced by COG112 treatment in a Schwann cell line S16. Moreover, COG112 significantly promoted axon elongation in primary dorsal root ganglion cultures from rat pups. Considering that cholesterol and lipids are needed for reconstructing myelin sheaths and axon extension, these data support a hypothesis where supplementation with exogenous apoE-mimetics such as COG112 may be a promising strategy for restoring lost functional and structural elements following nerve injury.
Li
Feng-Qiao
FQ
Cognosci, Inc., Research Triangle Park, NC 27709, USA. fli@cognosci.com
Fowler
Kenneth A
KA
Neil
Jessica E
JE
Colton
Carol A
CA
Vitek
Michael P
MP
D000595:Amino Acid Sequence; D000818:Animals; D001057:Apolipoproteins E / Q000737:chemistry* / Q000378:metabolism; D001369:Axons / Q000187:drug effects* / Q000378:metabolism; D015153:Blotting, Western; D004195:Disease Models, Animal; D005260:Female; D008077:Lipoproteins, LDL / Q000378:metabolism; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D046529:Microscopy, Electron, Transmission; D008969:Molecular Sequence Data; D009186:Myelin Sheath / Q000378:metabolism*; D009409:Nerve Crush; D009413:Nerve Fibers, Myelinated / Q000187:drug effects / Q000378:metabolism; D009416:Nerve Regeneration / Q000187:drug effects*; D010455:Peptides / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D012583:Schwann Cells; D012584:Sciatic Nerve / Q000187:drug effects / Q000293:injuries* / Q000648:ultrastructure; D020426:Sciatic Neuropathy / Q000188:drug therapy* / Q000378:metabolism; D016896:Treatment Outcome; D016138:Walking
D001057:Apolipoproteins E; C530207:COG112 peptide; D008077:Lipoproteins, LDL; D010455:Peptides
Neurobiol Aging. 2002 Sep-Oct;23(5):777-85
12392781
J Neurosci. 1997 Aug 15;17(16):6114-21
9236223
J Neurochem. 2006 Feb;96(3):833-42
16336221
Plast Reconstr Surg. 1989 Jan;83(1):129-38
2909054
Neurobiol Dis. 2002 Oct;11(1):214-20
12460559
J Clin Invest. 2008 Jan;118(1):161-72
18060043
J Clin Invest. 1989 Mar;83(3):1015-31
2493483
Neurology. 2001 Feb 13;56(3):312-6
11171894
Proc Natl Acad Sci U S A. 1983 Jul;80(13):4169-73
6575401
Neurocrit Care. 2006;4(1):25-31
16498192
Neuropharmacology. 2008 Aug;55(2):204-14
18602124
Prog Neurobiol. 2000 Jun;61(3):267-304
10727776
Proc Natl Acad Sci U S A. 1986 Feb;83(4):1125-9
2419900
Science. 1988 Apr 29;240(4852):622-30
3283935
Neuroreport. 1996 Nov 25;7(18):2897-901
9116205
J Neuroimmunol. 1997 Jun;76(1-2):70-4
9184634
Mol Pain. 2007 Nov 01;3:33
17974036
Exp Neurol. 2001 Jan;167(1):74-85
11161595
Neuroscience. 2003;116(2):437-45
12559098
Science. 1993 Aug 13;261(5123):921-3
8346443
Neuroscience. 1997 Nov;81(1):255-62
9300418
J Neuropathol Exp Neurol. 2000 Nov;59(11):1002-10
11089578
J Neurosci Methods. 2008 Aug 30;173(2):249-58
18644327
J Lipid Res. 1992 Nov;33(11):1677-88
1464751
J Pharmacol Exp Ther. 2006 Sep;318(3):956-65
16740622
Free Radic Biol Med. 2002 Jun 1;32(11):1071-5
12031891
Science. 1994 May 6;264(5160):850-2
8171342
Pain. 1988 Jan;32(1):77-88
3340425
Science. 1985 Apr 26;228(4698):499-501
3983637
J Cell Sci. 2009 Apr 15;122(Pt 8):1155-62
19299462
J Biol Chem. 2003 Dec 5;278(49):48529-33
14507923
Pharmacogenomics. 2007 Aug;8(8):959-69
17716229
Exp Neurol. 2005 Mar;192(1):109-16
15698624
J Neurocytol. 1995 Sep;24(9):667-79
7500122
J Biol Chem. 2008 Jun 13;283(24):16752-61
18417477
J Neurochem. 1991 Jun;56(6):2082-6
2027015
Curr Neuropharmacol. 2006 Oct;4(4):293-304
18654638
J Neurol Sci. 2002 Oct 15;202(1-2):69-74
12220695
Neurobiol Aging. 2009 Sep;30(9):1350-60
18155324
Biochemistry. 2004 Jun 15;43(23):7328-35
15182176